Shuai Lü

4.1k total citations · 1 hit paper
144 papers, 2.9k citations indexed

About

Shuai Lü is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Shuai Lü has authored 144 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 22 papers in Computational Theory and Mathematics and 21 papers in Organic Chemistry. Recurrent topics in Shuai Lü's work include Computational Drug Discovery Methods (22 papers), Alzheimer's disease research and treatments (12 papers) and Acute Myeloid Leukemia Research (10 papers). Shuai Lü is often cited by papers focused on Computational Drug Discovery Methods (22 papers), Alzheimer's disease research and treatments (12 papers) and Acute Myeloid Leukemia Research (10 papers). Shuai Lü collaborates with scholars based in China, United States and United Kingdom. Shuai Lü's co-authors include Rui‐tian Liu, Yadong Chen, Xiaoge Liu, Soumalya Bhattacharyya, Koushik Acharyya, Peter J. Stang, Tao Lu, Xiaolin Yu, Jie Zhu and Haichun Liu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Shuai Lü

131 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AGIEval: A Human-Centric Benchmark for Evaluating Foundation Models

2024 63 citations Shuai Lü et al. profile →

Peers

Countries citing papers authored by Shuai Lü

Since Specialization

Citations

This map shows the geographic impact of Shuai Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Lü more than expected).

Fields of papers citing papers by Shuai Lü

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Lü. The network helps show where Shuai Lü may publish in the future.

Co-authorship network of co-authors of Shuai Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Lü. A scholar is included among the top collaborators of Shuai Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Lü. Shuai Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Establishment of a clinically relevant beagle model for periprosthetic joint infection with 3D-printed prostheses and multimodal evaluation	Journal of Orthopaedic Translation	Tingting Fan, Rui Yuan et al.	0
2	Analysis on the Improvement of Formaldehyde Hazards in a Spray Painting Position in Automobile Manufacturing	E3S Web of Conferences	Shuai Lü, Zhi Wang et al.	0
3	Isolation and characterization of a novel K3-type capsule-targeting phage for the treatment of carbapenem-resistant Acinetobacter baumannii	Microbiology Spectrum	Ziqiang Liu, Siyun Wang et al.	0
4	Motor Signal Processing and Fault Diagnosis Based on an Analog Circuit Inspired by a Machine Learning Algorithm	IEEE Transactions on Instrumentation and Measurement	Juncai Song, Shuai Lü et al.	0
5	Ionic double-shell magnetic covalent organic framework for sharp and fast adsorption of critical metals	Separation and Purification Technology	Yan Cao, Shuai Lü et al.	6
6	Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations	European Journal of Medicinal Chemistry	Zhijie Wang, Xun Lu et al.	4
7	WMBAL: weighted minimum bounds for active learning	Applied Intelligence	Shuai Lü, Zhi Li et al.	1
8	CDKN1A regulation on chondrogenic differentiation of human chondrocytes in osteoarthritis through single-cell and bulk sequencing analysis	Heliyon	Chao Fang, Rui Zhong et al.	4
9	Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy	European Journal of Medicinal Chemistry	Zhijie Wang, Donglin Wu et al.	12
10	Rational design of 4-((6-phenoxypyrimidin-4-yl)amino)-N-(4-(piperazin-1-yl)phenyl)-1H-pyrazole-3-carboxamide (LT-540-717) as orally bioavailable FLT3 inhibitor	European Journal of Medicinal Chemistry	Yanle Zhi, Hongmei Li et al.	5
11	Hydrophobic tag-based protein degradation: Development, opportunity and challenge	European Journal of Medicinal Chemistry	Xiaofei Zhao, Donglin Wu et al.	33
12	Synthesis, structure elucidation and functionalization of sulfonamide [2]catenanes	Organic Chemistry Frontiers	Yu Wang, Shuai Lü et al.	13
13	FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance	Journal of Medicinal Chemistry	Jie Cheng, Hongmei Li et al.	67
14	Investigation of Machine Intelligence in Compound Cell Activity Classification	Molecular Pharmaceutics	Yanmin Zhang, Yi Hua et al.	7
15	Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1	Journal of Chemical Information and Modeling	Ting Ran, Wenjuan Li et al.	13
16	Combining structure- and property-based optimization to identify selective FLT3-ITD inhibitors with good antitumor efficacy in AML cell inoculated mouse xenograft model	European Journal of Medicinal Chemistry	Zhijie Wang, Hongmei Li et al.	13
17	A cis‐eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma	Cancer Medicine	Lijuan Meng, Yan Zhou et al.	13
18	Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation	European Journal of Medicinal Chemistry	Yanle Zhi, Haoliang Yuan et al.	18
19	Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia	Journal of Medicinal Chemistry	Yue Wang, Yanle Zhi et al.	89
20	Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation	Molecular BioSystems	Ting Ran, Zhimin Zhang et al.	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact